Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 03 - 15    symbols : NVS    save search
New Zolgensma data demonstrate age-appropriate development when used early, real-world benefit in older children and durability 5+ years post-treatment
Published: 2021-03-15 (Crawled : 11:00) - globenewswire.com
NVS | News | $92.61 -0.51% 430K twitter stocktwits trandingview |
Health Technology
 | | O: 0.25% H: 1.17% C: 1.13%
treatment children order
Molecular Partners and Novartis Announce Inclusion of COVID-19 Antiviral Candidate, ensovibep, in NIH-Sponsored ACTIV-3 Trial
Published: 2021-03-15 (Crawled : 10:00) - biospace.com/
NVS | News | $92.61 -0.51% 430K twitter stocktwits trandingview |
Health Technology
 | | O: 0.25% H: 1.17% C: 1.13%
covid antiviral molecular trial ensovibep
Gainers vs Losers
78% 22%

Top 10 Gainers
AGBA | $1.05 162.5% 100M twitter stocktwits trandingview |
Finance
INVO | $1.36 78.95% 3.6M twitter stocktwits trandingview |
Health Technology
BPTH | $5.62 73.46% 75M twitter stocktwits trandingview |
Health Technology
TIRX | $0.8231 69.78% 54M twitter stocktwits trandingview |

ISPC | $0.307 44.13% 3.6M twitter stocktwits trandingview |
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M twitter stocktwits trandingview |
Health Technology
XPON | $2.63 36.27% 8.4M twitter stocktwits trandingview |

ALRN | $5.53 30.12% 250K twitter stocktwits trandingview |
Health Technology
VTNR S | $1.26 28.68% 9.1M twitter stocktwits trandingview |
Industrial Services
HOLO | $2.86 27.68% 28M twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.